tiprankstipranks
ANEST IWATA Corp. (JP:6381)
:6381
Japanese Market
Want to see JP:6381 full AI Analyst Report?

ANEST IWATA Corp. (6381) AI Stock Analysis

0 Followers

Top Page

JP:6381

ANEST IWATA Corp.

(6381)

Select Model
Select Model
Select Model
Outperform 83 (OpenAI - 5.2)
Rating:83Outperform
Price Target:
Â¥2,203.00
â–²(34.82% Upside)
Action:Reiterated
Date:05/14/26
The score is driven primarily by strong financial quality (notably the very low leverage and solid profitability) and an attractive valuation (low P/E with a high dividend yield). Technicals are supportive with the stock above major moving averages, but slightly extended momentum and historically uneven cash conversion temper the overall rating.
Positive Factors
Conservative balance sheet
Exceptionally low leverage and steady equity growth provide durable financial flexibility. This reduces refinancing and solvency risk, allows funding of capex/dividends from internal resources, and supports strategic optionality (investment or M&A) over the next 2–6 months and beyond.
Negative Factors
Margin volatility
Fluctuating operating margins reduce earnings predictability and can compress returns during adverse input or mix shifts. Persistent margin variability signals exposure to cost inflation, product mix swings or operating-leverage effects that can impair long-term profitability consistency.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Exceptionally low leverage and steady equity growth provide durable financial flexibility. This reduces refinancing and solvency risk, allows funding of capex/dividends from internal resources, and supports strategic optionality (investment or M&A) over the next 2–6 months and beyond.
Read all positive factors

ANEST IWATA Corp. (6381) vs. iShares MSCI Japan ETF (EWJ)

ANEST IWATA Corp. Business Overview & Revenue Model

Company Description
Established in Yokohama, Japan, in 1926, ANEST IWATA Corporation is a global enterprise specializing in air energy and coating technologies. Its air energy division provides a broad range of products, including air compressors and nitrogen gas gen...
How the Company Makes Money
ANEST IWATA makes money primarily by manufacturing and selling industrial equipment and related components used in coating/painting and air/vacuum applications. Its revenue model is largely product-driven: (1) Coating-related products: sales of sp...

ANEST IWATA Corp. Financial Statement Overview

Summary
Strong overall fundamentals supported by steady revenue growth and solid profitability, plus an exceptionally conservative balance sheet with very low leverage and rising equity. The main offset is variability in operating margins and uneven cash conversion year-to-year.
Income Statement
78
Positive
Balance Sheet
90
Very Positive
Cash Flow
71
Positive
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue55.91B54.41B53.42B48.52B42.34B
Gross Profit26.14B26.08B24.48B21.34B18.23B
EBITDA8.05B8.39B8.43B7.91B6.54B
Net Income5.36B4.28B4.93B4.38B3.54B
Balance Sheet
Total Assets74.64B69.96B66.14B60.14B55.82B
Cash, Cash Equivalents and Short-Term Investments20.75B21.34B16.93B14.51B14.32B
Total Debt2.74B2.87B3.07B2.67B2.42B
Total Liabilities17.09B16.40B16.07B14.88B15.61B
Stockholders Equity50.75B46.85B44.16B40.03B35.62B
Cash Flow
Free Cash Flow4.94B7.08B4.95B2.48B3.02B
Operating Cash Flow8.14B9.75B6.77B4.33B3.89B
Investing Cash Flow-4.33B-3.25B-1.26B-3.32B-1.08B
Financing Cash Flow-3.86B-3.93B-3.58B-2.36B-2.10B

ANEST IWATA Corp. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1634.00
Price Trends
50DMA
1727.52
Positive
100DMA
1675.92
Positive
200DMA
1628.74
Positive
Market Momentum
MACD
49.64
Negative
RSI
80.91
Negative
STOCH
86.78
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6381, the sentiment is Positive. The current price of 1634 is below the 20-day moving average (MA) of 1807.40, below the 50-day MA of 1727.52, and above the 200-day MA of 1628.74, indicating a bullish trend. The MACD of 49.64 indicates Negative momentum. The RSI at 80.91 is Negative, neither overbought nor oversold. The STOCH value of 86.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6381.

ANEST IWATA Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
¥75.25B14.08―3.95%6.49%36.18%
75
Outperform
¥84.44B12.30―2.63%9.99%41.83%
74
Outperform
¥45.39B13.12―3.95%-2.07%6.34%
70
Outperform
¥82.26B10.95―3.09%0.93%212.09%
69
Neutral
¥105.58B19.31―2.79%7.86%19.30%
65
Neutral
Â¥239.32B17.499.52%1.33%4.34%98.54%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6381
ANEST IWATA Corp.
1,914.00
450.72
30.80%
JP:6376
Nikkiso Co., Ltd.
3,735.00
2,362.48
172.13%
JP:6237
Iwaki Co. Ltd.
4,605.00
2,190.23
90.70%
JP:6333
Teikoku Electric Manufacturing Co., Ltd.
3,235.00
11.22
0.35%
JP:6363
Torishima Pump Mfg.Co., Ltd.
3,180.00
1,156.66
57.17%
JP:6517
Denyo Co., Ltd.
4,145.00
1,225.07
41.96%

ANEST IWATA Corp. Corporate Events

ANEST IWATA Upgrades Interim Forecasts on Strong Overseas Demand and Weaker Yen
Aug 10, 2026
ANEST IWATA has raised its consolidated forecast for the first half of the fiscal year ending March 2027, citing stronger-than-expected sales of oil-free compressors and spray guns, particularly in overseas automotive refinishing markets, and the ...
ANEST IWATA Lifts Outlook on Strong Q1 and AI-Driven Compressor Demand
Aug 10, 2026
ANEST IWATA reported robust first-quarter results for fiscal 2026, with net sales rising 13.3% to 13.7 billion yen and operating profit climbing 32.8%, lifting its operating margin to 9.0%. Growth was driven by strong demand for oil-free scroll ai...
ANEST IWATA Delivers Strong Q1 FY2026 Results and Raises Dividend Outlook
Aug 10, 2026
ANEST IWATA reported a strong start to FY2026, with first-quarter net sales rising 13.3% year on year to ¥13.7 billion and operating profit jumping 32.8%, while profit attributable to owners of the parent climbed 27.0%. Despite a slight decli...
ANEST IWATA Advances Share Buyback, Purchasing Over Half of Authorized Shares
Aug 4, 2026
ANEST IWATA Corporation has reported the latest status of its ongoing share repurchase program, acquiring 342,900 common shares for approximately 602.5 million yen through market purchases on the Tokyo Stock Exchange between July 1 and July 31, 20...
ANEST IWATA Advances Share Buyback Under Board-Approved Program
Jul 3, 2026
ANEST IWATA Corp. has reported the latest progress on its ongoing share repurchase program, acquiring 118,200 common shares for 192,725,900 yen through market purchases on the Tokyo Stock Exchange between June 1 and June 30, 2026. These transactio...
ANEST IWATA Reports Initial Progress on 2026 Share Buyback Program
Jun 3, 2026
ANEST IWATA Corporation has disclosed the latest progress of its share buyback program, reporting the acquisition of 89,700 common shares for a total of ¥148,327,000 through market purchases on the Tokyo Stock Exchange between May 13 and May ...
ANEST IWATA outlines FY2025 results and Vision2035 growth strategy
May 19, 2026
ANEST IWATA released presentation materials for its FY2025 full-year financial results, outlining past performance and management’s view of the company’s current position. The materials also present its FY2026 plan, indicating a struct...
ANEST IWATA Sets Long-Term Strategy to Realize Vision 2035
May 12, 2026
ANEST IWATA Corporation has unveiled a long-term growth strategy as a master plan to achieve its Vision 2035, signaling a structured roadmap for its future development. The plan outlines how the group intends to steer its operations and investment...
ANEST IWATA Launches Share Buyback to Boost Capital Efficiency
May 12, 2026
ANEST IWATA Corporation has approved a new share repurchase program as part of its broader capital policy and commitment to enhancing shareholder returns. The company aims to use flexible buybacks while preserving a solid financial base to support...
ANEST IWATA to Expand Business Scope with Automotive-Related Services
May 12, 2026
ANEST IWATA Corporation plans to amend its Articles of Incorporation to broaden its stated business purposes, reflecting an expansion and diversification of its business domains across the group. The proposal, approved by the board, will be submit...
ANEST IWATA Doubles Annual Dividend and Adopts DOE-Based Payout Policy
May 12, 2026
ANEST IWATA Corporation’s board has approved a year-end dividend of JPY 46.00 per share for the fiscal year ended March 31, 2026, with a record date of March 31 and an effective payment date of June 29, subject to shareholder approval. This ...
ANEST IWATA lifts sales and net profit, forecasts margin squeeze amid 100th anniversary investments
May 12, 2026
ANEST IWATA reported FY2025 net sales of 55,909 million yen, up 2.8% year on year, with growth driven by strong air compressor demand from European OEMs and higher sales of coating equipment and systems in China, Japan and India. Despite revenue g...
ANEST IWATA Lifts Earnings and Dividends but Flags Profit Dip Ahead
May 12, 2026
ANEST IWATA reported fiscal 2025 consolidated net sales of ¥55.9 billion, up 2.8% year on year, with operating profit slipping 5.8% to ¥5.56 billion but ordinary profit rising 8.1% and profit attributable to owners of parent jumping 25.2...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 14, 2026